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More than 12,000 infants of nearly four million
babies born in the United States each year
are diagnosed with detectable and treatable
disorders. Most babies are screened at birth by
state newborn screening programs to detect
certain conditions that may threaten their
long-term health. If diagnosed timely, these
conditions can be successfully managed or
treated to prevent severe and often lifelong
health consequences. Each state determines
independently the conditions and screening
procedures for its screening program. States
varied widely on the number of conditions
for which infants were tested prior to 2006.
Moving toward standardization, the American
College of Medical Genetics (ACMG) in 2006
completed a report commissioned by the U.S.
Health Resources and Services Administration
(HRSA). The ACMG report recommended
that every baby born in the United States be
screened for 29 specific core conditions, and
each state should report test results for any of
the additional 26 specific secondary conditions
that may be identified incidentally during the
course of screening for the core panel. The U.S.
Department of Health and Human Services
(HHS) Advisory Committee on Heritable
Disorders in Newborns and Children (ACHDNC)
endorsed the report and its recommendations.
HHS recommends that every newborn screening
program include a Recommended Uniform
Screening Panel (RUSP) that currently includes
34 core disorders and 26 secondary disorders.
The RUSP is a list of conditions adopted by the
Secretary of Health and Human Services (HHS).
The ACHDNC provides recommendations to
the Secretary of HHS with regard to which
conditions ought to be included on the RUSP.
The Secretary then makes the final decision on
whether to add, or not add, a recommended
condition to the RUSP.
The Newborn Screening Saves Lives Act 
of 2008 and Reauthorization Act of 2014 
On April 24, 2008, The Newborn Screening Saves 
Lives Act of 2008 became public law (H.R. 3825; 
Report No. 110-570). The Act was reauthorized in 
2014 (P.L.113-240). 
This law directs the Centers for Disease Control
and Prevention (CDC), in consultation with
HRSA and the State Departments of Health (or
related agencies), to develop a national newborn
screening contingency plan for use by a state,
region, or consortia of states to ensure continuity
of critical operations in the event of a public health
emergency. The development of this framework
for state and local planning was required within
180 days of enactment of the legislation. The
Newborn Screening Saves Lives Reauthorization
Act of 2014 stipulated that the plan was to be
updated as needed and at least every five years. 
A. Purpose
The Newborn Screening Contingency Plan
Framework (known as the Framework) was
developed in 2010 and the document was revised
in 2015-16 in partnership with federal, state, local,
and non-governmental organizations engaged
in aspects of the newborn screening community.
This is the first update to the Framework as it
relates to newborn screening, which includes
screening for hearing loss and Critical Congenital
Heart Disease (CCHD).
The intent of the Framework is to facilitate 
collaboration among federal agencies and state, 
local, territorial, tribal, and regional efforts 
to screen newborns for identified conditions 
during a public health emergency. This effort is 
limited to those areas of the newborn screening 
system (screening test, diagnosis and follow-up, 
treatment and management, evaluation, and 
education), for which the state public health 
agency assumes an oversight role. 
B. Mission Essential Tasks 
• Developing a comprehensive continuity
of operations plan to include blood spot,
hearing, and CCHD screening.
• Contingency planning.
• Conducting hearing and CCHD screening
using appropriate equipment and
methodologies.
• Collecting blood spot specimens.
• Transporting blood spot specimens.
• Processing blood spot specimens.
• Reporting test results.
• Diagnostic testing of positive screen results. 
• Ensuring appropriate follow-up and care
prior to hospital discharge (or transfer)
for newborns who fail a CCHD screen or
do not pass a hearing screening.
• Locating affected and potentially
displaced populations.
• Ensuring the availability of treatment and
management resources.
• Educating families about newborn
screening.
• Continuity of communications processes,
such as Health Information Technology
(HIT).
• Training newborn screening contingency
respondents and stakeholders.
• Communicating newborn screening
contingency plan details to partners and
stakeholders.
• Coordinating the inclusion of state
newborn screening contingency plans
into the state’s overall preparedness plan.
Concept of Operations 
This document is intended to be used as a
framework by state and local health agencies,
laboratories, clinicians, and other organizations
that are part of the newborn screening system in
the United States. Each organization may use the
applicable sections of this framework to create
their plans. 
The goal of newborn screening programs
is improving the quality of life of newborns
through early diagnosis and treatment. Newborn
screening is organized as a system that includes
the following:
• Education – ongoing education of the
public, parents, and health professionals.
• Screening – testing newborns.
• Follow-up (including results reporting) –
rapid location, follow-up, and referral of
the screen-positive infant.
• Diagnostic confirmation – evaluation
of the infant with a positive screening
test (or fail/not pass) to make definitive
diagnosis or exclude the disorder.
• Short-term and long-term management
– rapid planning and implementation of
long-term therapy, medical, or surgical
intervention(s) as needed.
• Evaluation and continuous quality
improvement – validation of testing
procedures, assessment of the efficiency
of follow-up and intervention, and
assessment of the benefit to the patient,
family, and society.
The screening component is performed the 
following three ways: 
1) A heel stick should be done 24 to 48
hours after birth and before the baby
leaves the birthing facility. Collect a small
blood sample on special filter paper for
laboratory analysis to detect metabolic/
genetic disorders. If the baby is not born in
a hospital, the midwife, doctor, or health
professional should collect the blood
sample within 48 hours of birth and send it
to the newborn screening laboratory.
2) Screening for hearing loss should occur
before the baby leaves the birthing facility. If
not born in a hospital, the hearing test should
occur no later than one month after birth. 
3) Pulse oximetry to identify CCHD by
measuring the proportion of hemoglobin
that is oxygenated (e.g., the amount of
oxygen in the baby’s blood). Screening
should be performed after 24 hours of age or
prior to discharge from the birthing facility. 
4 U.S. Department of Health and Human Services Newborn Screening Contingency: Plan Version II  5                   
  


















   
  
 
Members of the newborn screening community 
have developed a Continuity of Operations Plan 
(COOP), which provides information for state 
and local stakeholders to develop plans to ensure 
continuity in the event of disaster or emergency. 
The COOP for a newborn screening program and 
its public health laboratories should have two 
basic features: 
1) Provide a comprehensive, pre-identified
list of all core testing, support activities
(including reporting), and supplies that
must be maintained if the laboratory or
birthing facility experiences a partial or
complete operational disruption.
2) Provide a prearranged plan of action to
ensure that all core activities are continued
without delay.
Effective Date, Implementation, 
and Revisions 
This Newborn Screening Contingency Plan 
Framework’s effective date will be two weeks 
after final publication and following the 
signatures from the Director of CDC and the 
Administrator of HRSA. The Framework will be 
updated and renewed on an as-needed basis. 
This document is subject to amendments based 
on changes to the standard operating procedures 
in stable situations and based on information 
gathered during and after a disaster. Such 
amendments, shall however, be subject to the 
same level of scrutiny as in the preparation of the 
initial document. 
Strategic and Operational Objectives 
and Supporting Actions 
Strategic objectives broadly define what should 
be achieved to ensure comprehensive newborn 
screening. Operational objectives outline specific 
goals to achieve and require supporting actions 
that must be accomplished in order to fulfill the 
strategic objective. Each state should ensure 
that their newborn screening contingency plan 
is integrated into the overall state preparedness 
plan. 
The Newborn Screening Contingency Planning 
Checklist provides the strategic and operational 
objectives and major activities in a checklist 
format. The responsible entities for each 
action are outlined in the Newborn Screening 
Contingency Planning Checklist. Each responsible 
entity must develop and maintain specific 
Standard Operating Procedures (SOPs) that 
detail how each activity is executed within their 
jurisdiction or scope of responsibility. SOPs 
should be reviewed and updated on a regular 
basis to ensure they reflect the current method 
the entity operates. The strategic objectives are 
supported by specific operational objectives, 
which are further supported by supporting 
actions (see Figure 1). Each action has an 
entity that is responsible for ensuring proper 
implementation of that supporting activity. 
Figure 1: Newborn Screening Strategic Objectives. 
Operational Objectives and Actions 
Common Roles and Responsibilities 
Federal Responsibilities:
Office of the Assistant Secretary for 
Preparedness and Response (ASPR):
The Office of the Assistant Secretary for 
Preparedness and Response was created 
under the Pandemic and All Hazards 
Preparedness Act (PAHPA) in the wake 
of Hurricane Katrina. ASPR focuses on 
preparedness planning and response; 
building federal emergency medical 
operational capabilities; countermeasures 
research, advance development, and 
procurement; and grants to strengthen the 
capabilities of hospitals and health care 
systems in public health emergencies and 
medical disasters. The office provides federal 
support and medical professionals through 
ASPR’s National Disaster Medical System, 
which augments state and local capabilities 
during an emergency or disaster. 
National Disaster Medical System (NDMS),
Department of Health and Human Services 
(HHS): The NDMS is supplemented by state 
and local medical resources during disasters 
or major medical emergencies. Medical 
response is led by HHS that coordinates 
the Disaster Medical Assistance Teams, 
which are groups of intermittent federal 
employees who volunteer to be on a 
designated team for NDMS. Teams of 35 
with a range of health and medical skills are 
typically deployed. Federalization of the 
program allows for addressing important 
issues, such as licensure and certification, 
liability, compensation, and coverage 
under the Uniformed Services Employment 
and Reemployment Rights Act (USERRA) 
regarding leave from employment and 
reemployment. Two pediatric teams in 
NDMS can address issues related to infants 
identified through newborn screening and 
specialty clinic patients. They are primarily 
generalist pediatricians with limited 
experience in the management of newborns 
and children living with a life-threatening 
disorder, whether or not identified through 
newborn screening. 
Centers for Disease Control and Prevention 
(CDC): The Office of Public Health 
Preparedness and Response (OPHPR) within 
CDC has primary oversight and responsibility 
for all programs that comprise CDC’s public 
health preparedness and response portfolio. 
OPHPR helps the nation prepare for and 
respond to urgent threats to the public’s 
health, such as natural, biological, chemical, 
nuclear, and radiological events. OPHPR 
carries out its mission by emphasizing 
accountability through performance, 
progress through public health science, 
and collaboration through partnerships. 
CDC supports a Clinician Outreach and 
Communication Activity (COCA), which 
establishes partnerships with national 
clinician organizations to communicate 
information about emergency and disaster 
events. 
CDC’s National Center on Environmental 
Health (NCEH): The Newborn Screening 
Quality Assurance Program (NSQAP) 
within NCEH provides laboratory support 
to newborn screening programs and 
is devoted to ensuring the accuracy of 
newborn screening tests in every state for 
conditions that are evaluated through dried 
blood spot (DBS) testing. NSQAP’s services 
include proficiency testing, development 
of quality control and reference blood spot 
materials, test development and transfer, 
filter paper evaluation, technical training, 
and consultation for recent and anticipated 
additions to the Recommended Uniform 
Screening Panel (RUSP). NSQAP also 
partners with the Association of Public Health 
Laboratories (APHL) to provide technical 
services and support for newborn screening 
laboratory practice, including oversight and 
administration of a filter paper repository 
for emergency use by newborn screening 
programs. 
CDC’s National Center on Birth Defects 
and Developmental Disabilities (NCBDDD).
NCBDDD provides clinical genetic and 
public health surveillance and epidemiology 
expertise to states. NCBDDD provides 
funding to support the development and
implementation of state-based Early Hearing
Detection and Intervention (EHDI) tracking
and surveillance systems, which help to ensure
that newborns are screened for hearing loss
and receive recommended follow-up. CDC also








    
    
    
    
    
    
    
   
    
    









    
    
    
  
    
   
    
   
    
 
  
    
   
  
  
   
  
   
  
   
   
   
   
   
   
   
   
   
funds 14 states to track major birth defects,
including CCHDs, using population-based
methods. State systems use the data to help
direct birth defects prevention activities and
refer children affected by birth defects to
needed services. 
Health Resources and Services 
Administration (HRSA): HRSA’s Maternal 
and Child Health Bureau (MCHB) oversees 
the Title V Maternal and Child Health 
Services Block Grant, which includes State 
Formula Block Grants, Special Projects of 
Regional and National Significance grants, 
and Community Integrated Service Systems 
grants. The largest portion of Title V funding 
goes to the states to meet critical challenges 
in maternal and child health and for 
monitoring systems of care, such as newborn 
screening for infants, children, youth, women 
of all ages, and pregnant women and their 
families. 
HRSA’s funded services provide: 
• Access to quality care, especially for 
people with low-incomes or limited 
availability of care 
• Assistance in the reduction of infant 
mortality 
• Access to comprehensive prenatal and 
postnatal care for women, especially 
low-income and at-risk pregnant 
women 
• An increase in health assessments and 
follow-up diagnostic and treatment 
services 
• Access to preventive and child care 
services as well as rehabilitative 
services for certain children 
• Family-centered, community-based 
systems of coordinated care for 
children with special healthcare needs 
• Toll-free hotlines and assistance in 
applying for services to pregnant 
women with infants and children who 
are eligible for Title XIX (Medicaid). 
In addition, HRSA/MCHB funds various 
newborn screening programs: 
• Improving the Timeliness of Newborn 
Screening Diagnosis Initiative seeks 
to ensure newborns receive timely 
screening, diagnosis, and treatment for 
heritable disorders. 
• Newborn Screening Technical 
Assistance and Evaluation Program 
(NewSTEPS) provides technical 
assistance on the implementation of 
state-based public health newborn 
screening and other genetics programs. 
• The Regional Genetics Networks with
an associated national coordinating
center to provide a regional
infrastructure of public
health genomics expertise to
improve, expand, strengthen,
evaluate access to a system of
genetic services, to improve health
outcomes for children, youth and
adults across their lifespan. 
• Severe Combined Immunodeficiency 
(SCID) Newborn Screening 
Implementation Program supports 
implementation of universal screening 
for SCID in every state, with all 
identified infants receiving appropriate 
screening and follow up care. 
• Newborn Screening Implementation 
Program Regarding Conditions 
Added to the Recommended 
Uniform Screening Panel supports 
implementation of universal 
screening for Pompe disease, 
Mucopolysaccharidosis I (MPS I), 
and X-linked Adrenoleukodystrophy 
(X-ALD). 
• Universal Newborn Hearing Screening 
and Intervention Program and two 
associated coordinating centers to 
support statewide and territorial 
Early Hearing and Detection and 
Intervention (EHDI) programs in their 
efforts to develop a comprehensive and 
coordinated system of care targeted 
towards ensuring that newborns and 
infants are receiving appropriate and 
timely services including screening, 
evaluation, diagnosis and early 
intervention. 
Director’s Critical Information Requirements 
(DCIRs): The CDC Director’s and HRSA 
Administrator’s Critical Information 
Requirements (DCIRs) are used as 
criteria or triggers to determine what 
information should to be communicated 
to CDC and HRSA leadership to assist in 
making critical decisions regarding both 
agencies’ preparation for and response 
to an emergency. If one of the DCIRs is 
met, it might trigger an increased level of 
awareness, increased contact with partners, 
event-specific planning, or initiation of 
response activities. The DCIRs applicable to 
newborn screening include: 
1. Report significant disruptions to 
state or regional newborn screening 
capabilities; 
2.Report any requests for CDC or HRSA 
assets or assistance in coordinating 
newborn screening in the event of a 
public health emergency; 
3. Report any significant disruptions in 
the availability of newborn screening 
treatment and management resources; 
4.Report any requests made by the 
HHS Secretary regarding execution of 
newborn screening activities; and 
5.Report any abnormal trends from 
newborn screening results. 
Non-Federal Responsibilities 
Newborn screening is a system cutting 
across governmental public health at all 
levels, hospitals and midwives, health plans, 
manufacturers, pharmacists, clinicians, 
advocacy organizations, couriers, and other 
entities. Staff members, who will provide 
newborn screening, should be made aware of 
the following: 
1. State and local coordination 
requirements. 
2. Non-governmental organization 
requirements. 
3. Private sector coordination requirements. 
4. Key federal decisions. 
5. Actions required of or prohibited by the 
federal government. 
Public health officials are subject to a host 
of laws and regulations. The following 
represents roles and responsibilities that 
should apply to a cross-section of all newborn 
screening partners: 
1. Establish policies and procedures to 
ensure continuous performance of critical 
testing and support activities. 
2. Ensure sufficient stock of critical supplies. 
3. Define requirements for continuous 
operations, then identify and prearrange 
for assistance from alternate states and 
laboratories, if needed. 
4. Ensure safety of all laboratory employees 
and visitors. 
5. Provide communication and direction to 
stakeholders. 
6. Minimize the loss of assets, resources, 
critical records, and data. 
7. Reduce or mitigate disruptions to the 
program’s operation. 
8. Build infrastructure to support a timely 
recovery. 
9. Manage the immediate response to the 
emergency. 
10. Provide prospective information 
and education for employees and 
stakeholders regarding roles and 
responsibilities during an emergency. 
11. Maintain, exercise, or audit the COOP at 
least annually. 
























    Figure 2: Newborn Screening Strategic Objective 
Flowchart 
Strategic Objectives Flowchart 
The flowchart (see Figure 2) provides 
an overview of strategic objectives and 
major actions that need to be sustained 
to ensure babies and their families receive 
these critically important services. 
1. Ongoing communication to families, 
providers, birth facilities, and agency 
staff is ensured. 
2. Families are educated about newborn 
screening. 
3. A framework for screening (blood 
spot, hearing, and CCHD) and 
specimen collection is established. 
4. Specimens are shipped to the 
designated newborn screening 
laboratory site. 
5. Specimens are processed and tested. 
6. Screening results are reported to the 
newborn screening follow-up program 
and physicians and families. 
7. Diagnostic testing is performed for 
infants with positive screening results 
for time-critical disorders. 
8. Availability of treatment and 
management resources is ensured. 
9. Other activities determined 
appropriate by the HHS Secretary are 
carried out. 
Specimens shipped to 
designated newborn 
screening laboratory 
site within 24 hours. 
How do you manage 
en-route missing dried 
blood spot (DBS) 
specimens? 
•  En-route DBS speci-
mens to impacted labs 
   should be redirected to
 appropriate labs. 
•  Missing/not shipped
 DBS specimens should
 be recognized, and new
 specimen obtained. 
Families are educated about newborn screening. 
Ongoing communication to families, providers, 
birth facilities, and agency staff is ensured. 
Families know about the need for 
newborn screening. 
Families with newborns who are screened 
know how to obtain newborn screening results. 
Families know what to do in response 
to newborn screening results. 
An effective newborn screening 
communication network is established. 
A plan for communications to all stakeholders 
during an emergency event is established. 
Multiple communication modalities 





What should be 
available? 
•  NSQAP-certified blood
 spot collection cards. 
•  Other materials
 required for blood spot
 collection hearing
 screening and pulse
 oximetry CCHD. 
•  Training on how to 
conduct blood spot 
and point-of-care
 screenings. 
•  Training and processes
 on how to collect and




What should be secured? 
•  Integrity of specimens 
and records of all DBS
 specimens sent to and
 received by back-labs. 
• All DBS specimens are
 processed. 
• Address emergency
 situation to preserve or
   restore capacity. 
What decisions should be 
made? 
•  The need for additional/
   alternative capacity. 
• Appropriate internal and
 external stakeholders to
   notify. 
•  Whether to activate back-
up lab system for managing
 external specimens. 
Carry out other activities determined appropriate 
by HHS Secretary. 
Screening results 
reported to physicians 
and families. 
What communication lines 




   coordinator. 
• NBS program and
physician or healthcare
   provider. 
• If healthcare provider is
not available, communi-
cation between NBS
 program and families
   should occur. 
What communication lines 
should be established? 
• All screening specimens
and results. 
•  Infants who are not
 screened. 
Diagnostic testing is 
performed. 
What actions should be 
taken? 
• Diagnostics testing and
tracking is ensured. 
• Diagnosis is established. 
• Results are 
communicated to the
   healthcare provider,
   family, and NBS
screening program. 
Availability of treatment 
and management 
resources is ensured. 
What should be identified 





• Access to and 
connection with a





• Connection to long-term
follow-up program and
services, if applicable. 
Preparedness issues are identified and addressed 
for NBS systems. 
Implementation, maintenance, and validation of the NBS 
Contingency Plan are performed by HHS. 
8 U.S. Department of Health and Human Services Newborn Screening Contingency: Plan Version II  9 





















































    
 
   
    
 

























    
 
 

























 I.  SITUATION 
A. Background 
Effective implementation of newborn
screening has had a significant place in the
United States public health arena for decades.
Non-governmental organizations, such as the
March of Dimes, have championed the cause
of newborn health for almost a century. CDC’s
Newborn Screening Quality Assurance Program
(NSQAP) which played an important role in the
quality assurance aspect of newborn screening,
celebrated its 30th anniversary in July 2008.
The Association of Public Health Laboratories
(APHL) established a subcommittee of its
Newborn Screening and Genetics in Public
Health Committee to develop a framework to
assist public health laboratories to prepare for,
and respond to, disasters caused by nature,
terrorism, and interruptions of testing materials
and supplies in 2004. The subcommittee
designed a checklist (Appendix A) that outlined
the various elements public health laboratories
must address to prepare for disasters that
disrupt newborn blood spot screening program
operations. A generic Model Memorandum
of Understanding/Agreement (MOU/MOA)
(Appendix B) was developed to include elements
for consideration by states that may need
assistance from other states using a mutual
assistance agreement. 
Hurricanes Katrina and Rita destroyed Louisiana’s 
state public health laboratory and eliminated the 
state’s ability to perform newborn blood spot 
screening in 2005. The chief of the Louisiana 
Public Health Laboratory determined that the 
state’s newborn screening program was one 
of the state’s highest public health priorities. 
Fortunately, the Iowa public health newborn 
screening laboratory, facilitated by the 
Emergency Management Assistance Compact 
(EMAC), was able to rapidly assume the screening 
of Louisiana’s newborns. After the hurricanes, 
HRSA, the HRSA-funded Regional Genetic and 
U.S. Department of Health and Human Services 
Newborn Screening Service Collaboratives, 
their national coordinating center, and APHL 
initiated a process to create regional newborn 
screening emergency preparedness plans and 
the CONPLAN. These plans were essential for 
preparedness and recovery from the effects of 
Hurricane Sandy in New Jersey and New York 
in 2012. These plans provided a mandate for 
emergency preparedness for all state newborn 
screening programs. 
EMAC provides a structure for emergency
support between states and territories where
requested resources can be shared. EMAC was
established by a federal law (Public Law 104-321)
and ratified by Congress in 1996. All 50 states,
the District of Columbia, Puerto Rico, Guam,
and the U.S. Virgin Islands are EMAC members.
The National Emergency Management
Association (NEMA) administrates this program.
The CONPLAN considers EMAC an essential
resource in supporting emergency preparedness
and response for newborn screening.
APHL served as the central point of contact
during these emergencies and assisted programs
in maintaining services. Stakeholders, including
the regional collaborations, HRSA, and the
APHL Newborn Screening and Genetics in Public
Health Committee, led to the development of
the 2010 CONPLAN. This updated document
was developed by an Advisory Committee of
newborn screening experts and stakeholders,
including federal, state, and local partners, and
family representatives (see Appendix F). 
B. Authorities 
• The Newborn Screening Saves Lives
Reauthorization Act of 2014
• Title V of the Social Security Act of 1935 
• Title XXVI of the Children’s Health
Act of 2000, “Screening for Heritable
Disorders” 
• Public Health Service Act of 1944 
C. Threat 
A state and site vulnerabilities analysis provide
a list of threats that might disrupt normal
public health functions, including newborn
screening program operations within laboratory
facilities (e.g., laboratory testing) and within the
community (e.g., patient follow-up, treatment).
Such threats fall into the following general
categories: 
• Extreme weather conditions 
• Major equipment failure 
• Prolonged personnel staffing issues 
• Extensive building damage 
• Compromised building utilities 
• Failed communication systems 
• Shortage of testing materials and
supplies 
• Civil disturbance 
• Acts of terrorism 
Each public health newborn screening program
should develop a comprehensive list specific to
its own facility. This could be coordinated and/or
informed by other organization analyses, such as
a health department’s Hazard and Vulnerability
Analysis (HVA). 
D. Critical Considerations 
(1) Many states lack sufficient resources to
ensure self-sufficiency through internal
back-up systems and redundancy
through regionalization. 
(2) Few states have the capacity to absorb
a significant increase in hospital-based
screens and screening volume for the
laboratory and follow-up functions in
the case of an emergency. 
(3) Because of the variation among
states in the disorders they screen
for, contingency newborn screening
programs in states that provide
screening assistance to states in need
might not have the capacity to screen
for all of the same conditions. 
Contingency newborn screening programs
might not have the capacity needed to follow up
with infants that tested positive. 
E. Critical Assumptions 
(1) National and/or regional back-up
systems, including birthing facilities
and redundancy, are required to ensure
continuity of newborn screening
operations. 
(2) Preparations and drills for newborn
screening contingencies must
occur before the need for their
implementation. 
II. MISSION 
CDC and HRSA will work with our public health newborn screening partners to assure
continuity to newborn care and to develop a comprehensive and uniform system of
screening infants born in the United States in the event of a public health emergency,
as specified in the Newborn Screening Saves Lives Reauthorization Act of 2014. 
Newborn Screening Contingency: Plan Version II  10                    11 
                  
 
 
   
  
    
   
    
    
    
    
     
 
 
    
    
    
    
    
    
   
   
    
    
 
  
   
 
    
   
    
    
 
 
    
   
    
   
  
 
   
   
    
   
    
   
   
   
   
   
   
    
 
 
    
 
 
    
 
    
 
    
 
    
 


















































    
     
 
 
   
 
   
   
     
     
 III. EXECUTION 
Concept of Operations 
1. General 
Federal Agencies and National Partners
• American Academy of Pediatrics (AAP) 
• American College of Cardiology (ACC) 
• American College of Medical Genetics
and Genomics (ACMG) 
• American Heart Association (AHA) 
• Association of Maternal & Child Health
Programs (AMCHP) 
• Association of Public Health
Laboratories (APHL) 
• Association of State and Territorial
Health Officials (ASTHO) 
• Centers for Disease Control and
Prevention (CDC) 
• Emergency Management Assistance
Compact (EMAC) / Federal Emergency
Management Agency (FEMA) 
• Health Resources and Services
Administration (HRSA) 
• National Center for Hearing Assessment
and Management (NCHAM) 
City, County and State Partners 
• State and local public health
departments 
• State and local public health department
laboratories (non-contract and contract) 
• State newborn screening program
directors 
• State and local public health
preparedness directors 
• State Homeland Security Agency 
• State Emergency Management Agency 
• State and local emergency management
officials 
• State Title V Maternal Child Health / 
Children and Youth with Special Health
Care Needs Directors
• Agency Communication/Press Offices 
U.S. Department of Health and Human Services 
Non-Governmental Organizations
• Joint Committee on Infant Hearing
(JCIH) 
• March of Dimes (MOD) 
• National Association of County and City
Health Officials (NACCHO) 
• NewSTEPs (Newborn Screening
Technical assistance and Evaluation
Program)
• National Coordinating Center (NCC) for
the Regional Genetic Networks 
• Patient Advocacy groups 
• Manufacturers of newborn screening
tests and supplies 
• Regional disaster organizations 
• Hospital associations 
Healthcare Service Partners 
• Hospitals 
• Clinics 
• Primary care and other physicians,
nurses, and allied health practitioners 
• Health professional associations 
• Case managers 
• Specimen delivery systems 
• Reference laboratories 
• Local disorder/family support groups 
2. Pre-alert or Activation
Responsibilities 
A. Manufacturer or supplier
responsibilities. 
• Adequate forward stocking established. 
• Alternate transportation plans
established including disaster
identification to allow travel in an
emergency. 
• Plan to provide equipment, training,
and/or supplies as needed to alternate
site(s) within a specific time frame. 
B. State Health Official Responsibilities. 
• Meet with EMAC coordinator to discuss
newborn screening contingency
planning. 
• Establish contingency plan that includes
newborn screening program and its
laboratory capabilities. 
• Amend or establish MOU/MOAs to
include newborn screening contingency
planning. 
• Establish contract with partners and
vendors to include newborn screening
contingency planning. 
It is outside the scope of this plan to address
state specific details for newborn screening
contingency planning. However, a state can
ensure a much smoother assistance process
being proactive and with a contingency plan
in place. When developing a state newborn
screening contingency plan, there are
several key factors to consider: 
o Coordination at all levels is imperative.
Consider pre-identifying potential
reciprocal laboratories and/or entering
into MOUs/MOAs with several partner
states in different geographic regions.
Identify hospitals that are appropriate to
accept a transferred newborn needing
immediate evaluation for a failed CCHD
screen and a hospital or diagnostic
center to diagnose hearing loss.
Consider developing a shared response
which could ease the testing load of any
one state. Consider taking advantage of
existing conferences, workshops, and
training to discuss newborn screening
contingency planning. 
o Redundancy is critical to ensure
continuity.  Redundancy should be
planned in-depth, such as multiple
methods to respond to a system or
component failure or a secondary
response identified should the primary
backup fail. Evaluate every aspect of
the newborn screening program and
determine what would happen if each
aspect failed. If an aspect is critical to the
newborn screening system functioning,
develop backups for team members,
equipment, facilities, and supplies. 
o Communication is critical. Lateral
(interstate) and vertical (interstate)
communication is essential when
reporting mechanisms for newborn
screening results or when standard
communication might be unavailable.
It is important to include online
reporting methods in the Standard
Operating Procedures (SOP). 
o Training tests the response network.
Regularly scheduled exercises and
reviews of the contingency plan should
be routine.
o Conduct drills. Consider performing
joint emergency drills with reciprocal
agreement states. Practice drills
provide opportunities to examine
quality assurance parameters. 
• Develop a state Continuity of Operations
(COOP) Plan. 
o Refer to Section 3, Considerations
for COOP Development (below),
for recommended considerations
regarding COOP planning. 
C. State Public Health Laboratory
Responsibilities.
• Establish backup testing methods or plans. 
• Obtain documentation that manufacturer 
or supplier has the following: 
o Adequate forward stocking
established. 
o Alternate transportation plans
established. 
Newborn Screening Contingency: Plan Version II  12                    13 
                  
    
 
     
 
     
    
 
 




    
 





    
 
    
 
   






















    
    
   
   
     
   
   
    
   










    
 
 
    
 
 
    
 
    
 
   
   
    
 
      
 
     
     
 
     
     
 
 




    
  
  
   
   
    
  
  
• Work with manufacturers or suppliers to
address situations where materials are
not delivered as scheduled, such as: 
o Cost of alternative testing
instruments, materials, or outsourced
testing, and 
o Cost of staff time to implement
alternate testing. 
• Collaborate with state and federal
agencies to harmonize laboratory
methods so that results are comparable
between states. 
• Establish interstate and regional
agreements for ensuring backup of
laboratory capacity in addition to EMAC
(for situations where EMAC may not be
activated). 
• Establish back-up plans to ensure
continuation of diagnosis and follow-up
services for infants who test positive. 
• Establish a public health laboratory
COOP (See next section for
recommended considerations when
developing a COOP).
C. Birthing facilities 
• Establish an EHDI and CCHD newborn
screening, tracking and follow-up COOP.
• For responsibilities specific to EHDI
or CCHD, please see Operational
Objectives 2, 3, 6 and 7. 
3. Considerations for COOP
Development for the Laboratory 
A COOP applies to all operations, infrastructure, 
and resources necessary to continue the 
laboratory activities deemed essential to fulfill 
governmental responsibilities. The nature of the 
work done in the public health laboratory requires 
that its COOP be developed as a special part of 
the business continuity plan of the agency within 
which it operates. A COOP for a public health 
laboratory should have two basic features: 
U.S. Department of Health and Human Services 
1) A Newborn Screening COOP provides a
comprehensive, pre-identified list of all
core testing, support activities, supplies,
and communications plans to report
positive screening results to healthcare
providers or families if the laboratory
experiences a partial or complete
operational disruption; and 
2) A COOP provides a prearranged plan of
action to ensure that all core activities
are continued without delay.
The scope of the laboratory COOP should
include all time-sensitive core activities of the
public health laboratory, including technology
and required support. The COOP should
also have the capability to scale down to
accommodate lesser disruptions. Specific plans
of action should be developed, and groups of
personnel should be identified and trained to
implement these predefined actions to ensure
timely recovery. Some items to consider in
COOP planning include, but are not limited to,
the following: 
On-site Operation: Short-Term 
(1) Emergency electrical power available for
the following: 
• Specimen accessioning; 
• Demographic entry or test reporting; 
• Instruments; 
• Laboratory information management
system; 
• Refrigeration; and 
• Heating and cooling work areas. 
(2) Maintain a 3-month supply of testing
materials. 
(3) Identify alternate water sources. 
(4) Ensure availability of data systems to
record integrity and timely transmission
of test results to providers and state
programs and telephones for continuous
access to communication. 
On-site Operation: Long-Term 
(1) Prioritize tests to be reported.
(Refer to the ACHDNC timeliness
recommendations and Society for
Inherited Metabolic Disorders statement
on defining time-critical conditions
citations in Appendix E: References.) 
(2) Identify states with same screening panels
and methodology and consider backup
plans in the event of an emergency.
(3) Identify states with similar reporting
mechanisms (e.g., Web-based, fax, and
voice response system). 
Off-site Operation 
(1) Identify contacts at offsite screening
facility, if specimens are being tested at
a different laboratory. 
(2) Establish Memoranda of Understanding 
(MOU) with neighboring states.
* (See Appendix B for example) 
(3) Establish a plan for compensation.* 
(4) Establish a plan for specimen transport. 
(5) Establish a plan for communication
of positive tests results to submitters,
providers or specialists. 
(6) Establish a plan for communication of all 
test results to submitters.
(7) Prepare for temporary relocation
of staff. 
• Identify in-house staff, and plan
for updated emergency contact
information. 
• Identify financial mechanisms for
travel and housing. 
(8) Establish a plan for access, retrieval,
and entry of all data into local
information system after local operation
is reestablished. 
(9) Establish a communication plan for
the development and delivery of Public
Service Announcements (PSAs) to
inform hospitals, midwives, providers,
and the public of process changes. 
(10) Establish a plan for return to normal
operations. 
* EMAC, if activated, will provide for MOUs and
reimbursement of eligible mission costs. 
4. Deployment
To be published by the State authority, as
required. 
5. Demobilization
Procedures for standing down the
plan should be developed and issued
by appropriate state authority
(as required). 
Newborn Screening Contingency: Plan Version II  14                    15 
                  
 





   
    
  
   
   
  
  
   
  
  














Legal issues: Numerous legal issues have to be 
considered in developing a contingency plan for 
newborn screening emergency preparedness. 
Memoranda of Understanding with those 
involved to provide backup services, interstate 
compacts, and other agreements can cover issues 
the states’ rules cover return and storage of 
materials, malpractice and liability of responders, 
and other factors. 
Legal Issues Involved in Interjurisdictional 
Agreements for NBS Contingency Planning 
The Emergency Management Assistance 
Compact (EMAC) is a national interstate mutual 
aid agreement that enables states to share 
resources during times of disaster. Initiating 
formal agreements (e.g., memoranda of 
understanding [MOU], contracts) is a useful 
mechanism to address questions and concerns 
regarding newborn screening prior to an 
emergency situation arising. When entering 
into an MOU or contract with another state, it 
might be useful to incorporate the following 
considerations. 
These are drawn from the Association for 
Public Health Laboratories (APHL) / Centers for 
Disease Control and Prevention (CDC)’s Policy 
Guide for Public Health Laboratory Test Service 
Sharing and the CDC’s guidance publication An 
Overview of Legal Considerations in Assessing 
Multijurisdictional Sharing of Public Health 
Laboratory Testing Services. The specific section 
where more information and specific examples 
can be obtained in either guide is noted. 
1 Policy Guide for Public Health Laboratory Test Service Sharing, Section 4.1, pp. 25. 
2 Policy Guide for Public Health Laboratory Test Service Sharing, Section 2.3, pp.7; Section 4.2, pp. 26; Section 4.3, pp. 28. 
3 An Overview of Legal Considerations in Assessing Multijurisdictional Sharing of Public Health Laboratory Testing Services, “Public Health Laboratory Fees”, pp. 
9. 
U.S. Department of Health and Human Services 
IV. OVERSIGHT, COORDINATION,
AND COMMUNICATIONS Payment. The ways in which state laboratories charge for test services 
performed in another state vary widely. Some 
jurisdictions prohibit these charges, some 
specify a fixed amount, and some permit full 
cost recovery, with certain laws exempting 
specific tests from being charged. 
3. Certification and Licensure 4 
Laboratories. The Clinical Laboratory 
Improvement Amendments of 1988 (CLIA) 
designate the provisions needed to permit 
testing of human specimens, including 
newborn screening specimens, for the 
prevention, diagnosis, or treatment of 
diseases. While CLIA likely does not preclude 
shared service agreements, it may be helpful 
to include a provision that addresses all 
necessary laboratory certifications. 
Personnel. Some states have laboratory 
personnel licensure requirements, and 
many of these states require out-of-
state laboratories to comply with these 
requirements when sharing test services. 
4. Emergency Management Assistance 
Compact 5 
Each state, the District of Columbia, Puerto 
Rico, Guam, and the U.S. Virgin Islands have 
each enacted essentially uniform Emergency 
Management Assistance Compact (EMAC) 
legislation which authorizes participating 
states to provide assistance during a state 
of emergency declared by the jurisdiction’s 
governor. 
Each jurisdiction’s EMAC statutes 
contains provisions pertaining to liability, 
reimbursement, and licenses and related 
requirements for public health laboratories 
during a declared emergency. EMAC laws 
1. Authority to Participate 
in Test Service Sharing1 
Although there is no express legal authority 
to enter into formal test service sharing 
agreements across jurisdictions, this is 
generally not precluded. Moreover, some 
jurisdictions’ EMAC agreements may include 
a provision for “temporary suspension of 
any statutes or ordinances that restrict 
the implementation of EMAC-authorized 
mutual aid.” Therefore, EMAC could be used 
to enable a state to engage in test service 
sharing if a standing prohibition exists. 
2. Liability and Payment 2, 3 
Two common concerns encountered in 
developing formal test service sharing 
agreements are the extent to which one state 
laboratory may be held liable for another 
state laboratory’s actions or omissions to act 
(i.e., liability) and how funds are transferred 
from one state laboratory to another (i.e., 
payment). These rank high as frequent 
barriers to test service sharing and should 
be discussed in conversations to develop the 
agreement. 
Liability. Negotiation of liability 
considerations should identify and allocate 
responsibility for possible risks involved in 
test service sharing between jurisdictions. For 
example, states may include indemnification 
provisions to specify which parties agree 
to compensate others for loss or damages 
incurred as a result of pre-defined incidents, 
such as inaccurate reporting of results, 
misuse or misplacement of specimens, and/ 
or breaches of privacy. 
should be consulted in developing your plan 
as they can inform what is currently written 
in state law and what points remain to be 
addressed. 
5. Privacy 6, 7, 8 
Public health laboratories are subject 
to federal and state laws that protect 
individuals’ privacy and the confidentiality 
of information related to their health. Of 
particular note are federal laws – the Health 
Insurance Portability and Accountability Act 
(HIPAA) and Health Information Technology 
for Economic and Clinical Health Act 
(HITECH) – and state-specific laws. 
HIPAA (1996) protects information that 
“identifies an individual or for which there is 
a reasonable basis to believe the information 
can be used to identify the individual” and 
was updated and strengthened in 2009 via 
HITECH. That act regulates the disclosure 
of patient-identifiable information by 
covered entities (e.g., health care providers, 
health plans, and health clearing houses) 
and their business associates (e.g., claims 
processors and data services) to public 
health entities. Public health laboratories 
are often considered covered entities (i.e., 
when located within a health department) or 
hybrid entities – and thus HIPAA compliance 
is mandatory. It will be important to clarify 
which state laboratories are covered entities, 
hybrid entities, or business associates when 
entering into shared service agreements. 
State privacy laws also need to be considered.
These laws often serve to supplement, and
in many cases go above and beyond, HIPAA
protections, so provisions may need to be set
in place to ensure these laws do not impact
implementation during an emergency. 
4 An Overview of Legal Considerations in Assessing Multijurisdictional Sharing of Public Health Laboratory Testing Services, “Laboratory Certifcation”, pp. 6. 
5 Policy Guide for Public Health Laboratory Test Service Sharing, Section 4.8.2, pp. 35 
6 Policy Guide for Public Health Laboratory Test Service Sharing, Section 4.4, pp. 29 
7 An Overview of Legal Considerations in Assessing Multijurisdictional Sharing of Public Health Laboratory Testing Services, “Laboratory Certifcation”, pp. 5, 10. 
8 Policy Guide for Public Health Laboratory Test Service Sharing, Section 4.4.1, pp. 29; Section 4.4.2, pp. 30 
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6. Disease Reporting Laws 9, 10 
Although state-specific reporting 
requirements (i.e., who is required to 
report, which diseases are reportable, to 
whom reports must be made, reporting 
time frames, report content, reporting 
methods, etc.) might influence shared service 
agreements and should be reviewed for 
potential implications, it is uncommon for 
these to raise specific challenges. 
7. In-State vs. Out-of-State Testing 
While most states conduct their own testing 
and follow-up of newborns within their 
jurisdiction, 14 jurisdictions participate in a 
contractual agreement in which specimens 
are sent to a centralized testing facility, and 
then results are sent back to the original state 
for follow-up. 
For states that do have a standing, non-
emergency agreement for inter-jurisdictional
testing, the same agreements may apply during
an emergency. For states that do not, it might
be useful to define a plan of action for inter-
jurisdictional test sharing during a declared
emergency, such as agreeing to only test for
disorders typically tested for in the original
state. For example, if State A typically only
screens for 30 disorders and has to send out to
State B - which usually screens for 38 disorders
- in an emergency, State B might agree only to
test for those 30 on State A’s screening panel.
8. Parental Consent 
While newborn screening is opt-out
across the country, jurisdictions vary in opt-
out or refusal procedures (e.g., for what
reasons one can opt out, forms required, etc.).
Jurisdictions should review their own refusal
procedures and the procedures of jurisdictions
they plan to enter into an agreement with,
which will inform the language and provisions
used in any agreement vehicle (e.g., State
A and State B agree that State A will abide
by State B’s refusal requirements to test for
specific diseases in an emergency). 
B. Coordination 
Pre-event Planning and Exercises: Contingency 
plans are only as good as the preparation to 
employ them. Periodic conferences that discuss 
details of newborn screening contingency plans 
and MOU/MOAs are highly beneficial tools to 
maintain attention on these plans and allow for 
periodic updates as needs or situations warrant. 
Everyone with an interest in newborn screening 
programs, including the public, providers and 
their institutions, and emergency responders, 
must assume overlapping responsibility for the 
continuation of all aspects of the program. 
C. Communications. 
Effective newborn screening communications 
support involves addressing issues that arise 
during the course of normal operations and 
planning, as well as COOP. Recommendations 
for consideration and inclusion in planning are 
outlined in Strategic Objective 1. 
Implementation requires immediate activation 
of the COOP notification team to contact all 
key individuals and groups to provide them with 
essential information and guidance. Among those 
that need to be contacted by the notification 
team are the following: 
• All required response teams. 
• State Health Officer. 
• State epidemiologist. 
• StateTitle V Maternal Child Health Director. 
• State Emergency Management 
• All affected agency leaders. 
• All laboratory staff. 
• All newborn screening program staff. 
• All affected submitters of samples and
specimens. 
• All alternative laboratories and newborn
screening programs that may be required to
assume core functions. 
9   Policy Guide for Public Health Laboratory Test Service Sharing, Section 4.7, pp. 33 
10 An Overview of Legal Considerations in Assessing Multijurisdictional Sharing of Public Health Laboratory Testing Services, “Disease Reporting 
Requirements”, pp. 10. 































APPENDICES: Appendix A: 
Newborn Screening Contingency Planning Checklist Framework 
Newborn Screening Contingency Planning Checklist 




Conplan Update Advisory Committee Members (2015-16) 
This checklist includes the strategic objectives, operational objectives, and major supporting actions that
should be considered when planning and preparing for newborn screening contingency operations. Not all
emergency situations are the same and not all of the identified items may be needed. Additionally, there
may be other items and issues that will need to be addressed that are not included in this plan.
Strategic Objective 1 
Ongoing communication to families, providers, birth facilities, and agency staff is ensured. 









Establish relationships with and identify contact informa-
tion for/established relationships with the following: 
Birth facilities – nursery and laboratory 
Known midwives 
Local family practice and pediatrician groups 
Appropriate specialists 
Families already identified with a newborn screening 
condition 
Employ multiple communication modalities: 
Phone: 
Emergency call-back systems 
Integrate with Health Alert Network 
Social Media (Facebook, Twitter) 
Text 
Email 
Family resource centers (e.g., Family Voices, 
Genetic Alliance) 
Radio & Television 
Program/Agency Website updates 
Streaming audio sessions 
Provide education and training on state newborn 
screening practices to the following: 
Families 
Providers 
Birthing facilities/midwifery practices 
Ensure education and preparedness messages are 
linguistically and culturally appropriate; communi-
cations are accessible to all populations; and that 
communication channels are in place for reaching all 
affected populations. 
Incorporate emergency processes into standard 
communications to stakeholders 
Ensure all 
stakeholders 
are aware of 

























• Title V MCH 
program 


















• Local Emergency 
Management 
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Appendix A: Newborn Screening Contingency Planning Checklist Framework
Strategic Objective 1 Continued 
Objectives Are the following activities/plans in place? Resources / Tips Responsible Entities 
Internal Communications: 
Define a call-back system for in-house staff, partners, 
and stakeholders. 
Test the system at least annually. 
Review and update the system at least semiannually. 
Store critical data needed for activation of the COOP at
an off-site location (or location accessible remotely) for 
ready access. 
Store necessary contact information for staff, stake-
holders, couriers, alternate laboratories, vendors, 
emergency management personnel, and key contact 
information for APHL, CDC, and HRSA on a secure site 
available remotely and/or on back-up servers that are 
housed in other areas. 
Store any relevant standard operating procedures 
needed to carry out COOP activities on a secure site 
available remotely. 
1.2 
A plan for 
communica-






Determine which types of emergency will require 
emergency communications and to whom. 
Create centralized communication hotline for newborn
screening. 
Educate stakeholders on how they will receive informa-
tion about newborn screening in an emergency. 
Incorporate the National Standards for Culturally 
and Linguistically Appropriate Services (CLAS)  into 
preparedness activities: 
Perform needs assessment and gap analysis. 
Develop key messages in appropriate languages in 
advance of emergency situations. 
Establish a plan for communication that is accessible 
to all populations, including deaf and hard of hearing, 
blind and low vision consumers. 
Consider devel-
oping a specific 
communication 
























• State EHDI 
Coordinator 
• Title V MCH 
program 













Objectives Are the following activities/plans in place? Resources / Tips Responsible Entities 
• Newborn screen-
ing program 
• Hospital Incident 
Command Staff 
• Birthing Facilities 
• Laboratory(ies) 






in place and 
utilized. 
Establish a variety of communication modalities, 
including: 
Agency email listserv 
Organizational listservs (e.g., APHL, AAP, etc.) 
Phone hotline (e.g., Health Alert Network or State 
HAN Coordinator) 
Social media (Facebook, Twitter) 
Text 
Family support groups and community networks 
Program/Agency Website 
Situations you 




lists can be chal-
lenging: 






















• State EHDI 
Coordinator 
• Title V MCH
program 















• Hospital Incident 
Command Staff 
• Birthing Facilities 
• Laboratory(ies) 
• Local Emergency 
Management 
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Appendix A: Newborn Screening Contingency Planning Checklist Framework
Strategic Objective 2 
Families are educated about newborn screening. 
Objectives Are the following activities/plans in place? Resources / Tips Responsible Entities 
2.1 Identify pregnant women and families with newborn State: 
Families of babies. • State Health 
newborns Deliver information about newborn screening at Official 
know about the time the specimen is obtained or point-of-care • Newborn 
the need for screening is performed. Screening 
newborn Ensure families understand the information. Program Director 
screening. Raise awareness of the public health functions of the 
State newborn screening program. 
• State EHDI 
Coordinator 
• Title V MCH 
program 





















Provide families with information and education on 
how to obtain screening results. 
Request alternate/emergency contact information for 
family on the newborn screening specimen kit. 
Add additional contact options (healthcare provider, 
state health department, etc.) at the bottom of the 
state testing pamphlet and a statement to for parents 
to ask their pediatrician about newborn screening 
results at baby’s first visit. 
Ensure that families know about point-of-care screen-
ing results prior to discharge. The baby with a failed 
CCHD screen will be evaluated prior to discharge 
from the hospital or birthing facility. If an infant fails 
a hearing screen, families should receive results and 
follow-up appointment information. 
State: 





• State EHDI 
Coordinator 
• State Title V MCH 
program 





















Provide families with information and education on 
how to obtain screening results. 
Request alternate/emergency contact information for 
family on the newborn screening specimen kit. 
Add additional contact options (healthcare provider, 
state health department, etc.) at the bottom of the 
state testing pamphlet and a statement to for parents 
to ask their pediatrician about newborn screening 
results at baby’s first visit. 
Ensure that families know about point-of-care screen-
ing results prior to discharge. The baby with a failed 
CCHD screen will be evaluated prior to discharge 
from the hospital or birthing facility. If an infant fails 
a hearing screen, families should receive results and 
follow-up appointment information. 
State: 





• State EHDI Coor-
dinator 
• State Title V MCH 
program 


















Assist families with appropriate course of action. 
0 Provide families information about access to care. 
0 Provide families with information on the potential 
meaning of a positive/not-pass/fail screen and need for 
confirmatory testing for diagnostic purposes. 
0 If testing confirms a diagnosis, provide information on 
short-term follow-up and linkage to specialty care. 
State: 





• State EHDI Coor-
dinator 
• State Title V MCH 
program 
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Appendix A: Newborn Screening Contingency Planning Checklist Framework
Strategic Objective 3 
Screens are conducted and dried blood spot specimens are collected and transported. 










that also allow 
follow-up are 
available for 




Identify a repository of blood spot collection cards for 
use by any U.S. newborn screening program.
 Ensure cards are not expired. 
Facilitate redistribution of locally available cards until 
supplies are exhausted. 
Notify and activate national repository to deliver cards 
in anticipation of local supplies being depleted.
 Facilitate distribution of cards to jurisdiction.
 Facilitate distribution of cards to collection points. 
State: 

































Ensure availability of materials required for blood spot 
collection, including lancets, alcohol pads, and packag-
ing at hospitals and other potential collection sites. 
Ensure availability of materials for CCHD screening, 
including pulse oximeters and probes designed for use 
in newborns, equipment and personnel for follow-up 
echocardiogram (on-site or by telemedicine), or iden-
tification of an alternate site with proper materials for 
further evaluation. 
Ensure availability of materials for hearing screening, 
such as OAE and ABR screening equipment and neces-
sary supplies (e.g., probes). 
State: 

































Train medical professionals who may be involved in 
dried blood spot collection. 
Train professionals who may be involved in conducting 
a CCHD screen on the jurisdiction’s defined protocol. 
Train professionals who may be involved in conducting 
a hearing screen using physiologic measures, such as 
OAE and/or automated ABR testing. 
Collect appropriate specimens and conduct 
appropriate point-of-care screens. 
Record accurate demographics and results of point-of-
care screenings (to allow complete screening, including 
follow-up testing). 
Maintain a log of all dried blood spot specimens 
collected or refused at the collection site. 
Make a decision about which laboratory to use. 
Identify alternate courier (if necessary) who will work 
in any emergency/disaster conditions (e.g., National 
Guard, state police, FedEx or UPS, local couriers, etc.). 
Inform hospitals and follow-up providers about 
changes in laboratory and/or couriers. 
Forward completed and dried blood spot specimen to 
shipping location. 
Report CCHD and hearing screening results to 
appropriate state program. 
Evaluate any newborn with a failed CCHD screen for 
the cause of low blood oxygen levels including CCHD 
prior to hospital discharge. Establish plans for transfer 
to another facility when indicated. 
State: 







• State EHDI 
Coordinator 
• Title V/MCH 
Director 
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Appendix A: Newborn Screening Contingency Planning Checklist Framework
Strategic Objective 4 
Specimens are shipped to the designated newborn screening laboratory site. 
Objectives Are the following activities/plans in place? Resources / Tips Responsible Entities 
4.1 Assess the situation and the operational status of Situations you State: 
Specimens are laboratories and transport system. may want to • State Health 
shipped to the Ship to primary laboratory, if available. Ship to consider: Official 
appropriate secondary or tertiary laboratories when necessary. Weather and • Newborn 
laboratory Operationalize tracking system to document chain of need for alter- Screening 
within 24 custody of specimens. nate couriers Program Director 
hours of Notify courier of any special pick-up or delivery issues Strikes by • State 
collection. (e.g., timing, or location). couriers Preparedness 
Consider Director 
local and state • State Hospital 
public entities, Preparedness 
such as the Na- Director 
tional Guard, 























• Local Emergency 
Management 
4.2 Notify courier of any special pick-up or delivery issues. Consider State: 
Specimens Contact transport system provider and execute change centralized • State Health 
en-route to of address. courier pick-up Official 
impacted site. • Newborn 
laboratories Screening 










• Courier Services 
• Local Emergency 
Management 











Locate the newborn and his/her family. 
Collect a second specimen. 
Use Public Service Announcements (PSAs) to aid in 
advising parents of newborns affected by an emergen-
cy incident when necessary. 
State: 













• Laboratory (ies) 
• Newborn screen-
ing program staff 
• Health care pro-
viders 
• Joint Information 
Center (JIC) 
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Appendix A: Newborn Screening Contingency Planning Checklist Framework
Strategic Objective 5 
Specimens are processed. 
Objectives Are the following activities/plans in place? Resources / Tips Responsible Entities 
5.1 Assess facilities, supplies, utilities, staff, informatics, Situations you State: 
Laboratory supply chain, transport systems, safety issues or work- may want to • State Health 
capability and ing environment, and communication systems. consider: Official 
capacity are Assess potential duration of interruption and disruption Reagents run- • Newborn 






Power outage: • State 
Back-up power Preparedness 
(batteries, Director 
generator) • State Hospital 
Be on priority Preparedness 
list with power Director 
company 
Local: 
Machines break: • Jurisdictional 
Examine health official 






























5.2 Evaluate potential risk to specimens and records. State: 
Integrity of Take appropriate corrective actions to ensure integrity • State Health
specimens and of specimens and records. Official 
records are Make a record of damaged or compromised specimens • Newborn Screening
secured. and records. Program Director 
Local: 
• Hospitals and 
other potential 
collection facilities 
• Laboratory (ies) 
• Newborn screening
program staff
• Health care 
providers 
Objectives Are the following activities/plans in place? Resources / Tips Responsible Entities 
5.3 Contact vendors, tech support, facilities, and main- State: 
Structural and tenance to determine if emergency repair support is • State Health 
equipment re- available. Official 
pairs are made Estimate time required to complete repairs. • Newborn Screen-
as indicated, 
if possible, to 
Initiate repairs as feasible.
Maintain record of any repairs made. 
ing Program 
Director 
preserve or re- Local: 





• Local Emergency 
Management 
5.4 Make a timely judgment whether existing resources State: 
Decision is are sufficient or if a back-up lab is needed. • State Health 
made regard- Identify the appropriate resources that are needed to Official 





capacity is Local: 





• Local Emergency 
Management 
5.5 Contact APHL and NewSTEPs. Ensure the State: 
If additional Contact State Emergency Manager with recommenda- back-up • State Health 
capacity is tions on the need to activate EMAC, if applicable. laboratory tests Official 
needed, seek Identify and contact back-up laboratory. for the same • Newborn Screen-
assistance or 
activate back-
Ensure that the back-up laboratory is CLIA approved 
and participates in the CDC NSQAP.




up plan. Establish disorder panel needs.
Identify and address or resolve major algorithm, IT, 
and methodological or protocol differences.
tory, especially 









• Local Emergency 
Management 
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Appendix A: Newborn Screening Contingency Planning Checklist Framework
Strategic Objective 5 Continued 
Objectives Are the following activities/plans in place? Resources / Tips Responsible Entities 
5.6 Notify personnel according to internal procedures. State: 
Appropri- Notify external stakeholders, State Health Officer, • State Health
ate internal State Title V Director, providers and sub-specialists, Official 
and external and the public, as needed. • Newborn Screening
stakeholders Program Director 
(including 
personnel) Local: 
are notified of • Newborn screening
change in programs 
process during • Hospitals and other
an emergency. potential collection
sites 
• Laboratory(ies) 
• Courier Services 
• Local Emergency
Management 
5.7 All entities submitting specimens keep a log of speci- State: 
A record of all mens submitted. • State Health
dried blood All entities receiving specimens keep a log of speci- Official 
spot speci- mens received. • Newborn Screening
mens sent to 
and received 
by the back-up 
laboratory is 
When possible and as feasible, compare records of 
transported specimens. 









• Courier Services 
5.8 Back-up laboratories sort external specimens. State: 
A system at • State Health 
the back-up Official 
lab for man- • Newborn 
aging external Screening 
specimens Program Director 
from routine 
collections is Local: 
activated. • Back-up labs 
5.9  Analyze specimens. State: 
Specimens  Report results to submitters. • State Health 
are analyzed  Report the positive results to the follow-up system. Official 
and results are Unsatisfactory and out-of-range are reported to appro- • Newborn 
reported. priate follow-up system.
 Request second specimen, if needed.
Screening 
Program Director 
 Return specimen to originating state. Local: 
• Back-up labs 
• Newborn 
screening program 
• Health care 
providers 
Strategic Objective 6 
Screening results are reported to physicians and families. 
Objectives Are the following activities/plans in place? Resources / Tips Responsible Entities 
6.1 -6.3 Between sending and receiving laboratories, hospitals, To address State: 
Communica- and newborn screening follow-up coordinators: variability in • State Health 
tion lines are Assess options for communication among laboratories, how results Official 
established hospitals performing CCHD and hearing screenings, are reported, • Newborn 
and utilized and newborn screening follow-up coordinator. consider: Screening 
to ensure Formulate communication strategy. Discussing Program Director 
reporting of Implement strategies for communication. data defini- • State EHDI 
results. 
Between newborn screening follow-up program and 
physicians/providers: 
Determine if newborn screening card submitter or phy-
sician of record is available. 
Identify alternative provider to report results, if needed. 
Report result to submitter or physician of record or 
alternative provider. 
Healthcare provider confirms to newborn screening 
coordinator that infant is in care. 
Between newborn screening program and families (if 
healthcare provider is not available): 
Locate family. 
Inform family of newborn screening results and need 
for additional care. 
Link family to healthcare provider, ultimately a primary
















to short term 
follow-up and 
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Appendix A: Newborn Screening Contingency Planning Checklist Framework
Strategic Objective 6 Continued 
Objectives Are the following activities/plans in place? Resources / Tips Responsible Entities 
6.4 Develop a registry of specimens collected, and hearing State: 
All screening and CCHD screens performed or refused. • State Health 
specimens Record all results – positive, not-pass/fail, unsatisfactory, Official 
and results are pass, and negative – in registry. • Newborn 
tracked. Resolve all open newborn screening follow-up cases. Screening 
Program Director 
• State EHDI 
Coordinator 
• State Title V MCH 
program 
Local: 









6.5 Match screening records with birth records to identify Depending on State: 
Infants who infants not screened. the emergency • State Health 
are not Contact families of infants who did not receive event and systems Official 
screened are newborn screening. impacted, get- • Newborn 







• State EHDI 
Coordinator 

































Strategic Objective 7 
Diagnostic testing is performed for infants with urgent positive screening results. 
Objectives Are the following activities/plans in place? Resources / Tips Responsible Entities 
7.1 Healthcare provider consults with appropriate Situations you State: 
Appropriate sub-specialist. may want to • State Health 
diagnostic Identify indicated diagnostic test(s) and laboratories. consider: Official 
testing occurs CCHD should be ruled out by a medical evaluation, Database for • Newborn 
and is tracked 
in a timely 
way. 
which may include the use of diagnostic echocardiogra-
phy that may involve transport to another facility if the 
birthing hospital is not equipped with echocardiogra-
phy or telemedicine. 
Collect and send samples to diagnostic laboratories. 
documentation 







• State EHDI 
Coordinator 
• Title V MCH 
Report infants not passing the hearing screening to the program 
state EHDI program along with information about if 
and to whom a referral was made. 
Report diagnostic test results to appropriate healthcare 
professionals, sub-specialists, designated state pro-


















family to get 
to clinics for 
follow-up. If 






7.2 Healthcare provider and sub-specialist confer regarding State: 
Diagnosis is diagnostic test results and establish diagnosis, as appro- • State Health 
established. priate. Official 
Identify and conduct additional diagnostic evaluations, • Newborn 
as appropriate. Screening 
Communicate results to family. Program Director 
Notify newborn screening program of results • State EHDI 
and diagnosis. Coordinator 
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Appendix A: Newborn Screening Contingency Planning Checklist Framework
Strategic Objective 8 
Availability of treatment and management resources is ensured. 
Objectives Are the following activities/plans in place? Resources / Tips Responsible Entities 
8.1 Identify a primary care provider and specialist(s). • In an emergen- State: 
Appropriate Appropriate healthcare provider and sub-specialist cy, it can be • State Health Official 
treatment and confer and discuss treatment recommendations and challenging to • Newborn Screening 




Provide acute or urgent care, if needed. 
Ensure infants identified with hearing loss are referred 





• State EHDI 
Coordinator 
• Title V MCH program 




need for a 
reconnection to 
a medical home 
can be empha-
sized. 
• The medical 









source for a 
complete and 
accessible 
record of a 
baby’s medical 









8.2 Establish a mechanism to track affected displaced Consider reaching State: 
Infants with populations. out to the follow- • State Health Official 
diagnoses re- Initiate chronic condition management. ing partners: • Newborn Screening




er and specialist(s). 
Refer to State Title V health department, CYSHCN 







• Title V MCH program 
established organization(s), and local resources to ensure access to emotional sup- Local: 
medical home. needed services and family support. 
Develop a treatment plan. 
Facilitate access to counseling and social services. 
Facilitate access to medical foods, pharmaceuticals, 
and devices. 
Establish reimbursement mechanisms for services. 
Ensure these efforts and plans are connected to the 
State CYSHCN and/or long term follow-up program, 















• Healthcare providers 





• Emergency Mgmt. 
Strategic Objective 9 
Carry out other activities determined appropriate by the HHS Secretary. 
Objectives Are the following activities/plans in place? Resources / Tips Responsible Entities 
9.1 Establish and maintain a national blood spot collection Federal: 
Preparedness card repository communication strategy. • HHS 
issues are Establish contingency plans for transfer of care (for 
identified and affected individuals) from one health care system to State: 
addressed for another. • State Health Official 
NBS systems. Educate families about the need for individualized 
emergency response plans. 
Search the NBS contingency plan for instructions to 
“activate” various mechanisms and make sure those 
mechanisms have already been established and are in 
place. 
Develop and follow a plan to periodically hold drills or 
practice the NBS contingency plan. 
Establish communications with state EMAC (i.e., each 
NBS program should establish these communication 
channels). 
Assess the NBS emergency operations plans that states 
have developed, and maintain an electronic library of 
such documents. 
Develop the mechanism or ability to assist with infor-
mation, data, or results management among states for 
• Newborn Screening 
Program Director 
• State EHDI 
Coordinator 
• Title V MCH program 
• State Hospital 
Preparedness 
Director 
• State Preparedness 
Director 
• State Emergency 
Management 
Director or designee 
Local: 
• Jurisdictional public 
health authority
NBS systems. 
Establish relationships (among jurisdictions) related to 
mutual aid for NBS systems. 
• Newborn screening 
program 
• Hospital Incident 
Command Staff 
• Birthing Facilities 
• Laboratory(ies) 
• Local Emergency 
Management 
9.2 –Imple- Federal: 
mentation, • HHS 
maintenance, 
and validation 
of the NBS 
contingen-
cy plan are 
performed by 
HHS. 
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Appendix B: 
Model Memorandum of Understand/Agreement (MOU/MOA) 
MODEL MEMORANDUM OF UNDERSTANDING
(Some states prefer Memoranda of Agreements)
Between 
State A Department of Health and 
State B Department of Health 
Purpose 
This Memorandum of Understanding (MOU) is being established between State A Department of Health
and State B Department of Health to provide reciprocal coverage, to the extent facilities and materials
are available, for each other in the case of natural disasters, terrorism, or other emergencies that could
temporarily cause a discontinuation of laboratory services to the citizens of the state. 
Emergency Support Services 
State A and State B agree to provide, on a temporary basis, laboratory support services to each other and/ 
or permit the affected Laboratory’s staff to work in the other’s public health laboratory to perform testing
in the event of a natural disaster, terrorist event, or other emergency that could close down mission critical
functions of State A or State B. 
Laboratory services provided on a temporary basis means no more than four (4) weeks of continuous
service for a single occurrence, unless the parties mutually agree in writing to extend the time period.
Where appropriate, laboratory staff from the affected laboratory may be assigned to work in the public
health laboratory that is designated to provide the support service s. Assigned employees will comply with
rules and regulations of the support laboratory. 
Funding 
The state laboratory that is confronted with a temporary emergency caused by a disaster agrees to
reimburse at a reasonable cost the laboratory providing the support services for the cost of reagents,
supplies, reproduction of laboratory reports, telephone costs, and shipping and postage fees upon
submission of an itemized invoice. 
Transportation and Delivery of Specimens or Samples 
It shall be the responsibility of the state laboratory confronted with the emergency to arrange for transport
of specimens or samples to the laboratory providing support services or space for laboratory testing. 
Chain of Custody 
All samples or specimens and physical evidence received under chain of custody will be maintained under
secure conditions during storage, testing, and retention of evidence until the case is resolved. Laboratory
staff involved in receipt of samples or specimens, or storage and testing agree to respond to court-ordered
subpoenas related to these samples or specimens and to testify in court if necessary. The state agency
or attorney(s) who requested the subpoenas will pay for all expenses associated with court appearances.
Disposal of samples or specimens and physical evidence received under chain of custody must be approved
in writing by the submitter or returned to the submitter for disposal. 
U.S. Department of Health and Human Services 
Contact Persons 
A contact person will be identified for laboratory testing in the cooperating laboratories named in this MOU
to allow immediate interaction, assessment of the situation, and appropriate arrangements necessary for
the unimpeded flow of services. The contact persons for each laboratory will be the Laboratory Director
whose signature is on this MOU or his/her successor or designated representative. 
Liability 
Nothing in this MOU will create any right of indemnification for the benefit of either party, and each party
shall be responsible for its conduct as provided by law. Nothing in this MOU will be deemed to waive any
immunity available to either party, including sovereign immunity. 
Terms and Termination 
Subject to any rights of termination hereinafter set forth, this MOU shall become effective immediately
upon all parties signing and shall remain valid for 12 months. This MOU may be reviewed, and it may be
renewed annually. 
This MOU may be terminated by either party with or without cause upon thirty (30) days advance written
notice. This MOU shall not be altered, changed, modified, or amended except by written consent of all
parties to the MOU. 
Signatories 
The signatories of this Memorandum of Understanding will be responsible for activating this MOU
whenever a disaster occurs in the Public Health Laboratory operation. 
For their respective State Laboratories: 
Laboratory Director Laboratory Director 
Date: _______________________________________ Date: ___________________________________ 
For the State Agencies: 
Commissioner Commissioner 
Department of Health Department of Health 
Date: _______________________________________ Date: ___________________________________ 
Newborn Screening Contingency: Plan Version II  38                    39 
                  
 
 
   
   
  
   
   
   
  
   
   
 





   
 
   
 
   
   
  
   
   
   
 
   







   
    
 
 
    
   
 
  
   
 
 
   
  
 










   
 
 




   
 
 
   
 
 
   
 
  














   
   
 
   









AAP ................ American Academy of Pediatrics 
ACC................. American College of Cardiology 
ACMG ............. American College of Medical
Genetics 
AHCP .............. Appropriate Health Care Provider 
AMCHP........... Association of Maternal & Child
Health Programs 
APHL .............. Association of Public Health
Laboratories 
ASTHO ........... Association of State and Territorial
Health Officials 
CCHD.............. Critical Congenital Heart Defect 
CDC ................ Centers for Disease Control and
Prevention 
CLIA................ Clinical Laboratory Improvement
Amendments
COCA ............. Clinician Outreach and
Communication Activity
COOP ............. Continuity of Operations Plan 
CONOPS......... Concept of Operations 
CONPLAN ...... Contingency Plan
CYSHCN ......... Children &Youth with Special
Health Care Needs 
OPHPR ........... Office of Public Health
Preparedness and Response 
DBS................. Dried Blood Spot 
DCIRs.............. CDC Director’s Critical Information
Requirements 
DOH................ Department of Health 




FEMA.............. Federal Emergency Management
Agency 
U.S. Department of Health and Human Services 
NCBDD ........... National Center on Birth Defects
and Developmental Disabilities 
HCP ................ Health Care Provider 
HIT.................. Health Information Technology 
HHS ................ U.S. Department of Health and
Human Services 
HRSA .............. Health Resources and Services
Administration 
LRN................. Laboratory Response Network 
MCH ............... Maternal Child Health 
MCHB ............. Maternal and Child Health Bureau 
MOA ............... Memoranda of Agreement 
MOU............... Memoranda of Understanding 
NBS ................ Newborn Screening 
NCBDDD ........ National Center on Birth Defects
and Developmental Disabilities 
NCC ................ National Coordinating Center
(Regional Genetic and Newborn
Screening Collaboratives)
NDMS............. National Disaster Medical System
New STEPs ..... Newborn Screening Technical
assistance and Evaluation
Program 
NGO ............... Nongovernmental Organization 
NSQAP ........... CDC’s Newborn Screening Quality
Assurance Program 
PH................... Public Health 
POR ................ Physician of Record 
PSA................. Public Service Announcement 
SOP ................ Standard Operating Procedure 
U.S.................. United States of America 
USERRA.......... Uniformed Services Employment
and Reemployment Rights Act 
VOIP ............... Voice Over Internet Protocol 
Appendix D: 
Additional Resources 
This appendix contains resources, templates, case
studies, state examples and other information
that may be helpful to states developing,
updating, and/or implementing their newborn
screening contingency plans. This list is neither
comprehensive nor exhaustive. 
Additional Background Resources 
Emergency Management Assistance Compact






EMAC’s 13 Articles: https://www.leg.state.
nv.us/nrs/NRS-415.html
Emergency Preparedness for Children with 
Special Health Care Needs. (Website) 
American Academy of Pediatrics. Available 
from: https://www2.aap.org/advocacy/
emergprep.htm
Planning & Record Keeping > Emergency 
Preparedness for Children with Special 
Needs. (Webpage). Seattle Children’s Center 




• Preparedness for Pediatric Practices –
Newborn Screening in Emergencies.
American Academy of Pediatrics. Available
from: https://www.aap.org/en-us/Documents/
disasters_newborn_screening_handout.pdf
• Public Health Preparedness Tools. (Website)
Agency for Healthcare Research and Quality,
U.S. Dept. of Health and Human Services.
Available from: http://archive.ahrq.gov/prep/.
• Women, Infants and Children (WIC) -





• Genetic/metabolic health care delivery
during and after hurricanes Katrina and Rita
- Andersson HC, Narumanchi TC, Cunningham
A, Bowdish B, Thoene J. Available at: http:// 
www.ncbi.nlm.nih.gov/pubmed/16311054 
• New Jersey Prioritizes Newborn Screening
Program in the Face of Hurricane Sandy.





• “Lab technician braves blizzard for results
that save newborn’s life” (2015, WCBV. 
com) – news story highlighting importance
of contingency planning during a blizzard





State Examples and Templates:
• The Heartland NBS Back-up Testing and
Quality Assurance Project – 2012 Poster
• Missouri Newborn Screening Laboratory
Emergency Response Plan – 2010
• Southeast Regional Genetics Collaborative
Emergency Management Strategic Plan
• Income Contract Template (Word Document)
- editable example of a state income contract,
which could be used to contract with another
state’s laboratory in situations that may not be
deemed a state emergency.
• Sample Emergency Management Assistance
(EMAC) Interstate Mutual Aid Request for
Assistance – Newborn Screening Example,
Kansas
Newborn Screening Contingency: Plan Version II  40 41 
                  
 
   
   
   
 
  
   
   
   
  
   
    
    
  
   
   
   




























• Advisory Committee on Heritable Disorders in Newborns and Children’s Recommendations on Timely
Newborn Screening Goals, 2015. Available from: http://www.hrsa.gov/advisorycommittees/mchbadvisory/
heritabledisorders/recommendations/index.html.
• Andersson HC, Narumanchi TC, Cunningham A, Bowdish B, Thoene J. Genetic/metabolic health care
during and after hurricanes Katrina and Rita. Molecular Genetics and Metabolism. 2006;88:3–6.
• Andersson HC, Perry W, Bowdish B, Floyd-Browning P. Emergency preparedness for genetics centers,
laboratories and patients: the SouthEast Region Genetics Collaborative strategic plan. Genet Med,
October, 2011
• CDC Emergency Operations Plan (2009).
• Emergency Preparedness for Newborn Screening and Genetic Services, American College of Medical
Geneticists (ACMG) (2009). Available from: https://www.acmg.net/StaticContent/PPG/Emergency_
preparedness_for_newborn_screening_and.12.pdf.
• Floyd-Browning P, Perry W, Andersson HC. Newborn Screening Results Reporting Survey: A National
Snapshot with Implications for Emergency preparedness. J Pediatr, 2013,162:955-7.
• Guidelines for the Public Health Laboratory Continuity of Operations Plan, Association of Public Health
Laboratories (APHL). Available from: http://www.aphl.org/MRC/Documents/PHPR_2011Feb_PHL-
Continuity-of-Operations-Guidelines.pdf
• Integrated Planning System (2009).
• Joint Committee on Infant Hearing. Year 2007 position statement: principles and guidelines for early
hearing detection and intervention programs. Pediatrics 2007;120:898–921.
• Kemper AR, Mahle WT, Martin GR, Cooley WC, Kumar P, Morrow WR, et al. Strategies for implementing
screening for critical congenital heart disease. Pediatrics. 2011;128(5):e1259-1267.
• National Security Decision Directive 47 (NSDD-47) approved by the President of the United States in July
1982.
• Oregon Practitioner’s Manual Newborn Screening Program 8th Edition, 2008.
• The Newborn Screening Saves Lives Act of 2008 and Newborn Screening Saves Lives Reauthorization Act of 2014.
• SIMD Position Statement:  Identifying abnormal newborn screens requiring immediate notification of the
health care provider, 2014. Society for Inherited Metabolic Disorders. Available from: http://www.simd.
org/Issues/index.asp.
• US Newborn Screening System Guidelines II: Follow-up of Children, Diagnosis, Management, and
Evaluation, 2000.
• Watson MS, Mann MY, Lloyd-Puryear MA, Rinaldo P, Howell RR. Newborn Screening: Toward a Uniform
Screening Panel and System—Executive Summary. Pediatrics. Suppl. Am Acad Pediatrics. DOI: 10.1542/
peds.2005-2633B 2006;117:296–307.
U.S. Department of Health and Human Services 
Appendix F: 
CONPLAN Update Advisory Committee Members 2015-16 
2015-16 Newborn Screening Contingency Plan Update 
Advisory Committee Members 
Laura Aird, MS
Manager, Disaster Preparedness and Response 
American Academy of Pediatrics 
Hans Andersson, MD, FACMG 
Director, Hayward Genetics Center, Karen Gore
Chair of Human Genetics, Tulane University
Medical Center 
Gerrit Bakker, BS 
Senior Director, Public Health Preparedness &
Security, Association of State & Territorial Health
Officials 
Stanton Berberich, PhD 
Program Manager Medical Screening,
State Hygienic Laboratory, University of Iowa 
Mary Castro Summers
Director, Family TIES of Massachusetts 
Carla Cuthbert, PhD, FCCMG, FACMG 
Chief, Newborn Screening and Molecular Biology
Branch and the Newborn Screening Quality
Assurance Program, Centers for Disease Control
and Prevention 
Sara Denniston 
Newborn Screening Follow-Up Coordinator 
Oregon State Public Health Laboratory 
Stephanie Dulin, MBA 
Deputy Director, National Center on Birth Defects
and Developmental Disabilities, Centers for
Disease Control and Prevention 
Lacy Fehrenbach, MPH, CPH 
Director of Programs, Association of Maternal &
Child Health Programs 
Debra Freedenberg, MD, PhD 
Medical Director, Newborn Screening & Genetics,
Texas Department of State Health Services 
Amy Gaviglio, MS, CGC 
Short Term Follow-Up Supervisor, Newborn
Screening Program, Minnesota Department of
Health 
Arthur Hagar, PhD, HCLD 
Director of Chemistry & Hematology 
Georgia Public Health Laboratory 
Cheryl Harris, MPH 
Program Administrator, Genetic Diseases and 
Healthy Homes & Childhood Lead Poisoning
Prevention Program, Louisiana Department of
Health & Hospitals 
Patrick Hopkins
Chief, Newborn Screening Laboratory 
Missouri State Public Health Laboratory 
Christine Mackie, MPH 
Senior Director of Family Health, Association of
State & Territorial Health Officials 
Ed McCabe, MD, PhD 
Medical Director, March of Dimes 
Jelili Ojodu, MPH 
Director, Newborn Screening and Genetics 
Association of Public Health Laboratories 
Nikia Sankofa, MPH, MPA 
Director, Breastfeeding Project, National
Association of County and City Health Officials
Debi Sarkar, MPH 
Chief, Genetic Services Branch, Maternal and Child
Health Bureau, Health Resources and Services
Administration 
Scott Shone, PhD 
Research Scientist 1 / Program Manager 
New Jersey Department of Health 
Newborn Screening Contingency: Plan Version II  42 43 

























































Appendix F: continued 
Janet Thomas, MD 
Director, Inherited Metabolic Diseases Clinic 
Children’s Hospital Colorado 
John. D. Thompson, PhD, MPH, MPA 
Supervisor, Short-term Follow-up 
Newborn Screening Program, Washington State
Department of Health 
Calondra Tibbs, MPH 
Senior Director, Safe and Healthy Families 
National Association of County and City Health
Officials 
Beth Vogel, MS 
Project Manager, NYMAC 
New York State Department of Health 
Johnna Watson, RN, BSN 
Chief, Newborn Screening Follow-Up and CCHD
Programs, Maryland Department of Health and
Mental Hygiene 
Carrie Wolf, MBS 
Research Scientist 2, Newborn Screening
Program, Minnesota Department of Health 
Guisou Zarbalian, MS, MPH 
Senior Specialist, Newborn Screening and




Program Associate, Child & Adolescent Health,
Association of Maternal & Child Health Programs 
Kate Taft, MPH 
Sr. Program Manager, CYSHCN, Association of
Maternal & Child Health Programs 
CDC Staff 
Eric Dziuban, MD 
Medical Officer, Division of Human Development
and Disability, Centers for Disease Control and
Prevention 
U.S. Department of Health and Human Services 
Marvin So, MPH 
Evaluation Fellow, Division of Human
Development and Disability, Centers for Disease
Control and Prevention 
Jessica Franks, MPH 
Health Communications Specialist, Division of
Human Development and Disability, Centers for
Disease Control and Prevention 
EHDI and CCHD Advisors 
Ginnie Abarbanell, MD 
Pediatric Cardiologist, Children’s Healthcare of
Atlanta 
Medical Consultant Division on Congenital and
Developmental Disorders, Centers for Disease
Control and Prevention 
Janet Farrell
EHDI Director, Massachusetts Department of
Public Health 
Alex Kemper, MD, MPH, MS 
Professor of Pediatrics, Duke School of Medicine 
Tammy O’Hollearn, LBSW
EHDI Director, Iowa Department of Public Health 
Matt Oster, MD, MPH 
Pediatric Cardiologist
Children’s Healthcare of Atlanta 
Medical Consultant, Division on Congenital and
Developmental Disorders
Centers for Disease Control and Prevention 
CDC Staff 
Pamela Costa, MA
Surveillance Team Lead/Research Health Scientist 
Division on Congenital and Developmental
Disorders
Centers for Disease Control and Prevention 
Tiffany Colarusso, MD, MPH 
Medical Officer, Division on Congenital and
Developmental Disorders
Centers for Disease Control and Prevention
Marcus Gaffney, MPH
EHDI Team Lead/Health Scientist, Division of
Human Development and Disabilit
Centers for Disease Control and Prevention
Jill Glidewell, MSN, MPH 
Health Scientist, Division on Congenital and
Developmental Disorders
Centers for Disease Control and Prevention 
Cynthia Hinton, PhD 
Health Scientist, Division on Congenital and
Developmental Disorders
Centers for Disease Control and Prevention 
Rachel Hulkower, JD, MSPH 
Public Health Law Program Legal Analyst 
Division of Human Development and Disability,
Centers for Disease Control and Prevention 
Georgina Peacock, MD, MPH
Division Director
Division of Human Development and Disability
Centers for Disease Control and Prevention 
Catharine Riley, PhD, MPH
Health Scientist/Senior Service Fellow, Division of
Human Development and Disability
Centers for Disease Control and Prevention 
Kim Van Naarden-Braun, PhD 
Epidemiologist, Division on Congenital and
Developmental Disorders
Centers for Disease Control and Prevention 
Newborn Screening Contingency: Plan Version II  44                    45 


